Cancer Liver

Posts Tagged ‘Therapy’

Product Description
This issue will educate the internist and general practitioner on colon cancer, as well as further educate the gastroenterologist and colon cancer researcher. It provides basic clinical knowledge, comprehensively reviews the data, and analyzes the latest discoveries. Specific topics include epidemiology, the various modalities of screening, CT colonography, endoscopic ultrasound, and colonoscopic polypectomy.

Colon Cancer Screening, Surveillance, Prevention, and Therapy, An Issue of Gastroenterology Clinics

Product Description

This fifth volume of the series, Methods of Cancer Diagnosis, Therapy, and Prognosis, discusses in detail the diagnosis, treatment, and prognosis of Liver Cancer. Both standard and emerging therapies for this cancer, written by expert oncologists/pathologists in this field, are included.

This fully illustrated volume:

• Is divided into 7 sections: Applications of Imaging, Resectable Liver Cancer, Unresectable Liver Cancer, Hepatocellular Cancer, Liver Colorectal Metastasis, Biliary Cancer, and Splenic Cancer.
• Discusses imaging modalities for diagnosis, treatment assessment, and prognosis.
• Includes descriptions of radial magnetic resonance imaging, helical computed tomography, magnetic resonance imaging, FDG-PET, contrast-enhanced sonography, multidetector-row computed tomography, and single photon emission computed tomography.
• Presents imaging methods for localized fibrous tumors of the liver, abdominal neoplasms, cholangiocarcinoma, gall bladder carcinoma, hepatic cellular carcinoma, extrahepatic disease, intrahepatic disease, focal liver lesions, biliary cystic tumors, extra hepatic bile duct carcinoma, and splenic metastases.
• Highlights methods for treatment of hepatocellular carcinoma (HCC) with thalidomide and transarterial treatment of hepatic malignancies.
• Discusses postoperative interferon alpha treatment of patients with HCC.
• Details the methods of immunohistochemistry, tissue microarray, and proteomic analysis for diagnosis and prognosis.

The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of liver cancer and other cancer types.

Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.

Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer

Product Description

This fifth volume of the series, Methods of Cancer Diagnosis, Therapy, and Prognosis, discusses in detail the diagnosis, treatment, and prognosis of Liver Cancer. Both standard and emerging therapies for this cancer, written by expert oncologists/pathologists in this field, are included.

This fully illustrated volume:

• Is divided into 7 sections: Applications of Imaging, Resectable Liver Cancer, Unresectable Liver Cancer, Hepatocellular Cancer, Liver Colorectal Metastasis, Biliary Cancer, and Splenic Cancer.
• Discusses imaging modalities for diagnosis, treatment assessment, and prognosis.
• Includes descriptions of radial magnetic resonance imaging, helical computed tomography, magnetic resonance imaging, FDG-PET, contrast-enhanced sonography, multidetector-row computed tomography, and single photon emission computed tomography.
• Presents imaging methods for localized fibrous tumors of the liver, abdominal neoplasms, cholangiocarcinoma, gall bladder carcinoma, hepatic cellular carcinoma, extrahepatic disease, intrahepatic disease, focal liver lesions, biliary cystic tumors, extra hepatic bile duct carcinoma, and splenic metastases.
• Highlights methods for treatment of hepatocellular carcinoma (HCC) with thalidomide and transarterial treatment of hepatic malignancies.
• Discusses postoperative interferon alpha treatment of patients with HCC.
• Details the methods of immunohistochemistry, tissue microarray, and proteomic analysis for diagnosis and prognosis.

The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of liver cancer and other cancer types.

Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.

Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer

Product Description
This issue will educate the internist and general practitioner on colon cancer, as well as further educate the gastroenterologist and colon cancer researcher. It provides basic clinical knowledge, comprehensively reviews the data, and analyzes the latest discoveries. Specific topics include epidemiology, the various modalities of screening, CT colonography, endoscopic ultrasound, and colonoscopic polypectomy.

Colon Cancer Screening, Surveillance, Prevention, and Therapy, An Issue of Gastroenterology Clinics

Product Description

This fifth volume of the series, Methods of Cancer Diagnosis, Therapy, and Prognosis, discusses in detail the diagnosis, treatment, and prognosis of Liver Cancer. Both standard and emerging therapies for this cancer, written by expert oncologists/pathologists in this field, are included.

This fully illustrated volume:

• Is divided into 7 sections: Applications of Imaging, Resectable Liver Cancer, Unresectable Liver Cancer, Hepatocellular Cancer, Liver Colorectal Metastasis, Biliary Cancer, and Splenic Cancer.
• Discusses imaging modalities for diagnosis, treatment assessment, and prognosis.
• Includes descriptions of radial magnetic resonance imaging, helical computed tomography, magnetic resonance imaging, FDG-PET, contrast-enhanced sonography, multidetector-row computed tomography, and single photon emission computed tomography.
• Presents imaging methods for localized fibrous tumors of the liver, abdominal neoplasms, cholangiocarcinoma, gall bladder carcinoma, hepatic cellular carcinoma, extrahepatic disease, intrahepatic disease, focal liver lesions, biliary cystic tumors, extra hepatic bile duct carcinoma, and splenic metastases.
• Highlights methods for treatment of hepatocellular carcinoma (HCC) with thalidomide and transarterial treatment of hepatic malignancies.
• Discusses postoperative interferon alpha treatment of patients with HCC.
• Details the methods of immunohistochemistry, tissue microarray, and proteomic analysis for diagnosis and prognosis.

The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of liver cancer and other cancer types.

Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.

Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer

Kidney Cancer Therapy Area Pipeline Report contains detailed information on the kidney cancer drug pipeline. This report provides insight into the pipeline status of kidney cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date. 

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

• Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
• Keep track of your competitors and partners by better understanding their product pipeline.
• Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
• Maintain a critical competitive advantage.

For more information, please visit :

http://www.aarkstore.com/reports/Kidney-Cancer-Therapy-Area-Pipeline-Report-14230.html

Or email us at press@aarkstore.com or call +919272852585